Health Care/Hospital
Eurisotop Responds to Market Demand for Deuterated Chloroform
SACLAY, France, Sept. 22, 2020 /PRNewswire/ -- Eurisotop, a wholly owned subsidiary of Cambridge Isotope Laboratories, Inc. (CIL), announced a capacity expansion of its deuterated chloroform production. Since its acquisition by CIL in 2001, Eurisotop has become a leading producer of deuterated NM...
2020-09-22 22:00
2280
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
RHEINBREITBACH and BONN, Germany, Sept. 22, 2020 /PRNewswire/ -- Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/Denmark, to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an...
2020-09-22 21:36
2838
Biorasi Commended by Frost & Sullivan for its Full-service Offering to Drive Rare Disease Patient Recruitment for CROs
SANTA CLARA, California, Sept. 22, 2020 /PRNewswire/ -- Based on its recent analysis of the North American contract research organization (CRO) market, Frost & Sullivan recognizesBiorasi, LLC with the 2020 North American Entrepreneurial Company of the Year Award. Biorasi's milestone-based, patie...
2020-09-22 21:00
2096
Switching to investigational once-weekly insulin icodec from other basal insulins demonstrated to be efficacious and well-tolerated for people with type 2 diabetes in phase 2 trial
BAGSVAERD, Denmark, Sept. 22, 2020 /PRNewswire/ -- Today, Novo Nordisk announced results from three phase 2 clinical trials for insulin icodec, an investigational once-weekly basal insulin analogue, which were presented during the 56th European Association for the Study of Diabetes (EASD) Annual ...
2020-09-22 20:53
2703
New Study Suggests GlycoMark® May Identify Highest Risk Patients with Prediabetes
RALEIGH, North Carolina, Sept. 22, 2020 /PRNewswire/ -- According to new data presented at the 56th European Association for the Study of Diabetes (EASD) annual meeting, the GlycoMark blood test reflects beta-cell functional mass, which is important in identifying prediabetic individuals with the...
2020-09-22 19:00
1731
TCM Lianhua Qingwen Capsule approved for registration in Mauritius
SHIJIAZHUANG, China, Sept. 22, 2020 /PRNewswire/ -- Yiling Pharmaceutical Co., Ltd. (SHE: 002603) announced on Tuesday that it has received a registration approval issued by the Ministry of Health and Wellness ofMauritius, indicating Lianhua Qingwen Capsule has been registered in accordance with ...
2020-09-22 15:21
1741
Gates Foundation Honors Director of Africa CDC With 2020 Global Goalkeeper Award
Foundation also announces three Global Goals award winners and launches two innovative partnerships to address COVID-19 impacts inKenya SEATTLE, Sept. 22, 2020 /PRNewswire/ -- The Bill & Melinda Gates Foundation today named Dr. John N. Nkengasong, director of the Africa Centres for Disease Contr...
2020-09-22 12:01
2778
Kazia Enters Clinical Collaboration With Dana-farber Cancer Institute For Primary CNS Lymphoma
SYDNEY, Sept. 22, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has entered into a collaboration with Dana-Farber Cancer Institute (DFCI) inthe United States, to investigate the use of...
2020-09-22 09:21
7595
Israeli Pain Monitoring Startup Medasense Raises $18M in Series C Round
Accelerating Commercialization of its Novel Pain Monitoring Solutions RAMAT GAN, Israel, Sept. 22, 2020 /PRNewswire/ -- Medasense Biometrics Ltd., developer of the NOL technology for pain-response monitoring, today announced that it has raised$18M in a series C round, from Sabadell Asabys venture...
2020-09-22 06:30
2962
Vection Secures First Hospital Trial
PERTH, Australia, Sept. 22, 2020 /PRNewswire/ -- Real-time software company Vection Technologies Ltd (ASX:VR1) has signed a first public hospital to trial its Augmented Reality healthcare solutions. Vection Technologies will collaborate with the AORN S.G. Moscati hospital and LUISS Business Sch...
2020-09-22 06:17
2618
Qatar Foundation's WISE Announces Special E-Book
Education Disrupted, Education Reimagined - Responses from education's frontline during the COVID-19 pandemic and beyond DOHA, Qatar, Sept. 22, 2020 /PRNewswire/ -- WISE, a Qatar Foundation global education think-tank, in partnership with Salzburg Global Seminar, and Diplomatic Courier, is pleas...
2020-09-22 06:14
3409
Amazfit Band 5 Launched with Blood Oxygen Saturation, 15-day Battery Life[1] at 49.9USD[2] on Sept. 21st, and Amazon Alexa Built-in[3] Coming Soon
Can A Band Be Smarter? Check this All-round Band with Varied Health Management and Alexa Built-in. SHENZHEN, China, Sept. 21, 2020 /PRNewswire/ -- Amazfit Band 5, a smart wrist band, launched as the latest offering of Huami to the excellence of Amazfit wearable lineup. Amazfit Band 5 featur...
2020-09-22 00:00
5652
![Amazfit Band 5 Launched with Blood Oxygen Saturation, 15-day Battery Life[1] at 49.9USD[2] on Sept. 21st, and Amazon Alexa Built-in[3] Coming Soon](https://photos.prnasia.com/prnvar/20200917/2919079-1)
Zhongchao Inc. Reports the First Half of Fiscal Year 2020 Financial Results
SHANGHAI, Sept. 21, 2020 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced its unaudited financial results for the ...
2020-09-21 21:21
6476
Ortho Awarded BARDA Contract to Accelerate Antigen Test Development and Additional SARS-CoV-2 Antibody Test Milestones
RARITAN, N.J., Sept. 21, 2020 /PRNewswire/ -- Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced its continued collaboration with the Biomedical Advanced Research and Development Authority ( BARDA), part of the Office of the Assistant Secretary for Preparedness an...
2020-09-21 21:00
2081
Harbour BioMed Announces Two China NMPA Clearances for Clinical Trials for Phase I & Combination Therapy of Next Generation Anti-CTLA-4 Antibody for Treatment of Solid Tumors
CAMBRIDGE, Mass. and ROTTERDAM, Netherlands and SUZHOU, China, Sept. 21, 2020 /PRNewswire/ -- Harbour BioMed (HBM), a global, clinical-stage, innovative biopharmaceutical company announced approval of two Investigational New Drug (IND) applications by the China National Medical Products Administr...
2020-09-21 20:12
3587
Artificial Intelligence, Tele-ophthalmology, and IoT to Drive the Ophthalmic Diagnostic and Monitoring Devices Market
COVID-19 pandemic is pushing the demand for contactless ophthalmic diagnosis and portable handheld devices, finds Frost & Sullivan SANTA CLARA, California, Sept. 21, 2020 /PRNewswire/ -- Frost & Sullivan's recent analysis,Emerging Technologies Driving Growth Opportunities in Ophthalmic Diagnosti...
2020-09-21 19:03
1717
Hyde Engineering + Consulting Announces New VP of Global Engineering
BOULDER, Colorado, Sept. 21, 2020 /PRNewswire/ -- Hyde Engineering + Consulting, Inc. (Hyde) announced thatSanjay Shah has accepted the position of Vice President of Global Engineering. Sanjay, based out of Hyde's office in Ahmedabad,India, will provide subject matter expertise in conceptual an...
2020-09-21 11:30
2966
Key Milestone: The first patient successfully dosed with the candidate drug SR419 for peripheral neuropathic pain
SHANGHAI, Sept. 21, 2020 /PRNewswire/ -- Shanghai SIMR Biotechnology Co., Ltd. (hereinafter referred to as "SIMR" or "Company") announced that, the clinical trial in patients with peripheral neuropathic pain has been initiated for the candidate drug SR419, and the first patient has been successfu...
2020-09-21 10:35
2197
UN75 Dialogue - Family Mask and its #BackToSchool Initiative for Global Goals Week 2020
HONG KONG, Sept. 21, 2020 /PRNewswire/ -- To celebrate United Nations and its 75 th anniversary, Family Mask organized #KIDsforSDGs program which achieved great success and received feedbacks on global issues and role of the UN from the students. Family Mask collected all the feedbacks and will la...
2020-09-21 09:38
3038
Viva Biotech and SYNthesis Enters a Strategic Acquisition Agreement, Accelerating the Development of Global Innovative Drug R & D Service Capabilities
SHANGHAI, Sept. 21, 2020 /PRNewswire/ -- Viva Biotech (Shanghai) Co., Ltd. (hereinafter referred to as "Viva Biotech" or "The Company") entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to acquire and the Vendors agreed to collectively sell 100% of the equity interes...
2020-09-21 09:25
3392
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00
Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
[Picked up by 286 media titles]
2024-04-19 13:25
Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43
INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 271 media titles]
2024-04-24 17:09
Most Read
Combining Sustainability and Cybersecurity: Century Iron & Steel and Century Wind Power Both Receive ISO 27001 Information Security Certification
2024-04-19 18:03
9178
China's Yiwu Establishes Welcoming Committee to Attract International Buyers
2024-04-19 13:25
7753
Automation Anywhere Appoints Tim McDonough as Chief Marketing Officer to Drive Global Awareness and Growth for the Leader in AI-Powered Automation
2024-04-24 03:57
4199
